Lung Cancer

  1. Alecensa (alectinib)
    Alecensa (alectinib)
    by Roche Registration GmbH
    for Lung Cancer
    €7,350.00
  2. Alunbrig (brigatinib)
    Alunbrig (brigatinib)
    by ARIAD Pharmaceuticals, Inc.
    for Lung Cancer
    €3,657.00
  3. Imfinzi (durvalumab)
    Imfinzi (durvalumab)
    by AstraZeneca Pharmaceuticals LP
    for Urothelial Carcinoma, Lung Cancer
    €1,495.00
  4. Keytruda (pembrolizumab)
    Keytruda (pembrolizumab)
    by Merck Sharp & Dohme Limited
    for Urothelial Carcinoma, Gastric Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Skin Cancer
    €1,480.50
  5. Opdivo (nivolumab)
    Opdivo (nivolumab)
    by Bristol-Myers Squibb Pharma EEIG
    for Urothelial Carcinoma, Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer
    €498.00
  6. Portrazza (necitumumab)
    Portrazza (necitumumab)
    by Eli Lilly Nederland B.V.
    for Lung Cancer
    €672.75
  7. Tagrisso (osimertinib)
    Tagrisso (osimertinib)
    by AstraZeneca AB
    for Lung Cancer
    €8,619.25
  8. Tecentriq (atezolizumab)
    Tecentriq (atezolizumab)
    by Roche Registration Limited
    for Urothelial Carcinoma, Lung Cancer
    €6,463.00
  9. Zykadia (ceritinib)
    Zykadia (ceritinib)
    by Novartis Europharm Limited
    for Lung Cancer
    €6,037.50
View as Grid List

9 Items

per page
Set Descending Direction

Just one thing before you continue

Our service contains information about acquiring treatments that have been approved in another country. This includes professional information such as approval details, product information and pricing. By scrolling, you are declaring that you are requesting any such information.

No, take me out of here.
CONTINUE